• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Heng Ren Calls on Sinovac to Pay Shareholders the Special Dividend Before the July 8 Board Vote

    6/16/25 9:00:00 AM ET
    $SVA
    Major Pharmaceuticals
    Health Care
    Get the next $SVA alert in real time by email

    BOSTON, June 16, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA) shareholder Heng Ren Silk Road Investments LLC today sent an open resolution to Sinovac's shareholders outlining the decisive action that Sinovac's Board of Directors must take to pay shareholders the $55 cash dividend before the July 8 board vote, which would remove uncertainty, restore credibility and improve investor confidence in Sinovac.

    The full text of the resolution follows:

    Pay The $55 Dividend Before the July 8 Board Election

    All Sinovac shareholders can agree on one issue: receiving dividends.

    Heng Ren urges the Sinovac board to pay the declared $55 cash dividend before the July 8 vote for the board.

    Here are the reasons:

    • It's legitimate. The current board's announcement of the $55 special cash dividend payment date stated "on or about" July 9. Then Monday, July 7 should work. U.S. banks and stock exchanges are open for business.
    • A July 7 payment date would remove uncertainty about the dividend. After the current board declared a $55 cash dividend to be paid "on or about" Wednesday, July 9, the election contest for the Sinovac board was scheduled for the day before, July 8.
    • Given the drama surrounding Sinovac, it is not surprising that shareholders are worried that a different board might cancel the declared $55 dividend. Remove this worry. Pay the dividend on Monday, July 7 to shareholders.
    • Paying the dividend on July 7 focuses shareholders on the qualifications of the candidates. It reduces the guessing about where candidates stand on the single issue of dividends, and allows for a more holistic and realistic consideration of the candidates' merits to serve shareholders.

    This is a simple solution that would go a long way towards restoring credibility and investor confidence at Sinovac.

    Peter Halesworth

    Founder & CIO

    Heng Ren Silk Road Investments LLC

    Heng Ren Silk Road Investments LLC This week Heng Ren will invite shareholders to attend a webinar on the voting process and the issues before voters. Please review your voting materials and bring your thoughts and questions. See https://www.hengreninvestment.com/ and click "Sinovac Fairness" for details.

    Contact:

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/heng-ren-calls-on-sinovac-to-pay-shareholders-the-special-dividend-before-the-july-8-board-vote-302482377.html

    SOURCE Heng Ren Partners

    Get the next $SVA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SVA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SVA
    SEC Filings

    See more
    • SEC Form 6-K filed by Sinovac Biotech, Ltd.

      6-K - SINOVAC BIOTECH LTD (0001084201) (Filer)

      6/18/25 9:04:51 PM ET
      $SVA
      Major Pharmaceuticals
      Health Care
    • SEC Form 6-K filed by Sinovac Biotech, Ltd.

      6-K - SINOVAC BIOTECH LTD (0001084201) (Filer)

      6/18/25 2:09:19 PM ET
      $SVA
      Major Pharmaceuticals
      Health Care
    • SEC Form 6-K filed by Sinovac Biotech, Ltd.

      6-K - SINOVAC BIOTECH LTD (0001084201) (Filer)

      6/18/25 8:03:53 AM ET
      $SVA
      Major Pharmaceuticals
      Health Care

    $SVA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SINOVAC Board of Directors Prevails Against Advantech/Prime's New York Lawsuit

      New York Court Denies Advantech/Prime's Petition for Emergency Injunctive Relief Clears Legal Hurdle for Dividend Paying Agent to Payout the Special Cash Dividend of US$55.00 Per Common Share on July 7, 2025 SINOVAC Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced it has prevailed against Advantech/Prime Success' ("Advantech/Prime") Petition for Emergency Injunctive Relief in the U.S. District Court for the Southern District of New York. The result in the New York court represents another failure in the campaign by Advantech/Prime in coordination with Vivo Capital (together known as the "Dissenting Inves

      6/20/25 10:56:00 PM ET
      $SVA
      Major Pharmaceuticals
      Health Care
    • SINOVAC Board of Directors Files Definitive Proxy Materials

      Files definitive proxy statement and mails letter to shareholders Urges shareholders to VOTE the WHITE proxy card and vote "AGAINST" the misguided proposals to remove SINOVAC's Board and appoint the Reconstituted Imposter Former Board Slate The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced it has filed its definitive proxy materials with the Securities and Exchange Commission (SEC) for the Special Meeting of Shareholders to be held on Wednesday, July 9, 2025 at 8:00 a.m. China Standard Time (Tuesday, July 8, 2025 at 8:00 p.m. Atlantic Standard Time). In conjunction with t

      6/18/25 2:18:00 PM ET
      $SVA
      Major Pharmaceuticals
      Health Care
    • SINOVAC Announces New Board Member

      Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a resignation notice from David Guowei Wang, a member of the board of directors (the "Board") and a member of the Audit Committee, Compensation Committee and the Corporate Governance and Nominating Committee of the Board, effective immediately. Mr. Wang's resignation was due to increased professional commitments and time constraints and was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Board has appointed Geoffrey C. Hsu, CFA, as a director to the Boar

      6/18/25 4:38:00 AM ET
      $SVA
      Major Pharmaceuticals
      Health Care